Study of Safety and Tolerability of DCR HBVS

NCT03772249 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

82

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis B, Chronic

Interventions

DRUG: DCR-HBVS
DRUG: Placebo for DCR-HBVS

Sponsor

Dicerna Pharmaceuticals, Inc., a Novo Nordisk company